SK Biopharm, Foreign Investors Net Sell 1,000 Shares... Stock Price Down 2.63%
SK Biopharm has ranked among the top searched stocks on 6 days within the past month.
As of 12:32 PM on the 16th, SK Biopharm is trading at 156,000 KRW, up 2.63% from the previous day. This is a 9.04% decrease compared to September 15.
Over the past 5 days, individual investors have net purchased 229,338 shares, while foreigners and institutions have net purchased 151,164 shares and net sold 353,640 shares, respectively.
On October 14, SK Biopharm was a market highlight for its "strong performance on a 580 billion KRW epilepsy drug export deal to Japan."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
